Mannkind Corp (NASDAQ:MNKD)

During the Trading Day
4.37 +0.19 / +4.55%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.45 +0.08 / +1.83%
Volume: 32.0K
Health Technology

Company Description

MannKind Corp. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. The company's product AFREZZA inhalation powder, which is an ultra rapid-acting insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. MannKind was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Valencia, CA.

Contact Information

MannKind Corp.
28903 North Avenue Paine
Valencia California 91355
P:(661) 775-5300
Investor Relations:
(661) 295-4784



Individual stakeholders37.54%
Mutual fund holders14.19%
Other institutional10.58%

Top Executives

Hakan S. EdstromPresident, Chief Executive Officer & Director
Juergen A. MartensChief Operating Officer & Chief Technology Officer
Matthew J. PfefferCFO, Vice President & Head-Investor Relations
David B. ThomsonSecretary, Vice President & General Counsel
Robert A. BaughmanSenior Vice President-Clinical Sciences

To view my watchlist

Not a member yet?

Sign up now for a free account